Acura Pharmaceuticals, Inc. (ACUR)
| Market Cap | 6.65K |
| Revenue (ttm) | 1.56M |
| Net Income (ttm) | -879.00K |
| Shares Out | 66.50M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 400 |
| Average Volume | 21,259 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0004 |
| 52-Week Range | 0.0001 - 0.7532 |
| Beta | 66.61 |
| RSI | 44.62 |
| Earnings Date | n/a |
About Acura Pharmaceuticals
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ... [Read more]
Full Company ProfileFinancial Performance
In 2021, Acura Pharmaceuticals's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$879,000, -27.24% less than in 2020.
Financial StatementsNews
Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03
Amendment Extends NDA Acceptance Date Amendment Extends NDA Acceptance Date
Acura Pharmaceuticals Provides Development Update on LTX-03
PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and acetaminophen) tablets using Acura's LIMITx tech...
Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results
PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technolog...
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technolog...